OR WAIT null SECS
MJH Life Sciences
Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.
April 02, 2020
Whether refitting existing spaces or building new, the need for quick build times, flexibility, and production efficiency is driving trends in bio/pharma facility construction.
Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs.
April 01, 2020
Tools help improve understanding of excipient risk in formulating OSD drugs.
Understanding European GMPs and new rules from China for excipients are crucial for formulating solid-dosage drugs.
March 18, 2020
Technologies and methods for new and refurbished manufacturing facility construction expand capacity for new modalities and to ease shortages.
March 02, 2020
Understanding of scale-up parameters and use of process analytical technology are important to meet demand for larger batch sizes.